Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Journalist reported killed in the Gaza Strip - 2Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks
- 36 Fledgling Cameras for 2024: Ideal for New Photographic artists
- 4Portugal among EU countries with the most people working close to 50 hours a week
- 5Improving as a Pioneer: Examples from My Vocation
- 6 Exemplary Mexican Dishes
- Palestinians protest against Israel's new death penalty law
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- The Delight of Camper Vans: Choosing the One That Meets Your Requirements
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Journey Travel Objections for Your Next Experience
- Finding China: Four Urban areas for a Remarkable Excursion
- Trump administration plan to reduce access to some student loans angers nurses, health care groups
- Trial of pro-Palestine activist begins
